Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Samil Pharmaceutical Co., Ltd.
Age
19–55
Sex
MALE
Healthy volunteers
Accepted
You may be eligible if
Healthy male subjects between the ages of 19 and 55 years
Subjects who don't have congenital or chronic diseases and have no abnormal medical examination results within 3 years
Healthy Subjects (no clinically relevant findings in any of the investigations of the pre-examination) as judged by the investigator
Subjects who signed and dated in informed consent form indicating that the subject has decided to participate in the study after being informed of all pertinent aspects of the study
Subjects who are willing and able to comply with all scheduled visits, treatment plan, laboratory tests, and other study procedures
You may not be if
Evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease (but excluding untreated, asymptomatic, seasonal allergies at time of dosing)
Any condition possibly affecting drug absorption, distribution, metabolism, and excretion (e.g. gastrectomy)
Twofold or more than upper limit of normal range in laboratory test for ALT or AST
Participating in other clinical trial study within 2 month preceding the first dose of investigational product
History of significant alcohol abuse or drug abuse within one year prior to the screening
Whole blood donation within 2 months prior to dosing, or apheresis donation within 1 month prior to dosing
Other severe acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with study participation or investigational product administration or may interfere with the interpretation of study results and, in the judgment of the investigator, would make the subject inappropriate for entry into this study
Unwilling or unable to comply with the lifestyle guidelines described in this protocol
Subjects who are inadequate for this study to participate judged by investigator
Clareo Health | To Evaluate the Drug-drug Interaction Between Telmisartan and Atorvastatin in Healthy Male Volunteers
